Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The National Institutes of Health (NIH) is the primary agency of the United States government responsible for biomedical and public health research. Founded in the late 1870s, NIH has produced extraordinary advances in the treatment of common and rare diseases and leads the world in biomedical research. It is a critical national resource that plays an important role in supporting national security. The 310-acre Bethesda campus supports some 20,000 employees and contractors, and it contains more than 12 million square feet of facilities divided amongst nearly 100 buildings, including the largest dedicated research hospital in the world. The Bethesda campus supports some of the most sophisticated and groundbreaking biomedical research in the world. However, while some new state-of-the-art buildings have been constructed in recent years, essential maintenance for many facilities and the campus overall has been consistently deferred for many years. The deteriorating condition of NIH's built environment is now putting its ability to fulfill its mission at substantial risk. Managing the NIH Bethesda Campus' Capital Assets for Success in a Highly Competitive Global Biomedical Research Environment identifies the facilities in greatest need of repair on the Bethesda campus and evaluates cost estimates to determine what investment is needed for the NIH to successfully accomplish its mission going forward.--

National Institutes of Health (U.S.) --- Medicine --- Finance --- Management. --- Research

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Public health --- Research --- United States. --- National Institutes of Health (U.S.)

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

"To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24-25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop"--

Drug development --- National Institutes of Health (U.S.) --- Research --- United States. D0(DNLM)D014481 --- United States. --- Drug development.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

November's thoroughly researched and lively study makes clear for readers the motives behind computerizing the study of life and how that technology profoundly affects biomedical research today.

United States Government Agencies --- History, 20th Century --- Medical Informatics Computing --- Biomedical Research --- history --- National Institutes of Health (U.S.) --- Medical informatics --- Bioinformatics --- History.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Prepared at the request of the National Toxicology Program, this landmark report reveals that many chemicals used in pesticides, cosmetics, drugs, food, and commerce have not been sufficiently tested to allow a complete determination of their potential hazards. Given the vast number of chemical substances to which humans are exposed, the authors use a model to show how research priorities for toxicity testing can be set.

Toxicity testing. --- Toxicity testing --- National Toxicology Program (U.S.) --- Poisons --- Toxicological testing --- Toxicology --- Toxicology testing --- Testing --- United States. --- National Institute of Environmental Health Sciences. --- National Institutes of Health (U.S.). --- NTP --- National Cancer Institute (U.S.). --- Toxicology, Experimental